Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Algol Pharma
Espoo, Finland
- Ownership
- Private
- Development stage
- Other
01
Overview
Algol Pharma was a prominent pharmaceutical sales and marketing company operating across the Nordic and Baltic regions. The company specialized in the distribution, registration, and marketing of prescription drugs, over-the-counter (OTC) products, and healthcare equipment on behalf of international partners. In 2016, Algol Pharma was acquired by the French pharmaceutical group Biocodex, leading to its integration into Biocodex's Nordic operations. Prior to the acquisition, it served as a key bridge for global life science companies looking to enter the Northern European markets.
- Modalities
- Small moleculeBiologicVaccine
- Industry
- Drug Discovery Services
02
Partnerships
Beyond the preview
Go deeper on Algol Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Algol Pharma.